Myrexis, Inc.
OTC: MYRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Jonathan Couchman
- Employees
- 1
- Headquarters
- New York City, United States
- IPO year
- 2009
- Market cap
- $27.6K
- Website
- https://www.myrexis.com
Loading MYRX…
Loading profile data…Frequently asked questions about MYRX
What does Myrexis, Inc. (MYRX) do?
Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceuticals, Inc. until its rebranding took place in July 2010. Its main corporate offices are situated in New York, New...
Where does MYRX trade?
Myrexis, Inc. (MYRX) trades on the Other OTC.
What sector is MYRX in?
Myrexis, Inc. (MYRX) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Myrexis, Inc.?
Jonathan Couchman is the chief executive officer of Myrexis, Inc. (MYRX).
Where is Myrexis, Inc. headquartered?
Myrexis, Inc. is headquartered in United States.
Does MYRX pay a dividend?
Myrexis, Inc. (MYRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MYRX go public?
Myrexis, Inc. (MYRX) completed its initial public offering in 2009.